Armune BioScience
Kalamazoo, US · Delaware corporation
Founders & leadership
DA
David A EspositoExecutive
SC
Susan CrookstonExecutive
Board
DR
Donald R ParfetBoard director
JS
James SollinsBoard director
DP
Dennis P KaneBoard director
Reported raises · per SEC filings
Form D private placements$10.2M disclosed across 2 rounds · 2015–2017
▶$500KraisedJan 2017 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedJan 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Donald R ParfetDirector
- James SollinsDirector
- Dennis P KaneDirector
- David A EspositoExecutive Officer, Director
- Susan CrookstonExecutive Officer
- Offering amount
- $2M
- Amount sold
- $500K
- Minimum investment
- $50K
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.7MraisedJul 2016 · 47 investors · BiotechnologyRule 506(b)
▶$9.7MraisedJul 2016 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David A EspositoExecutive Officer, Director
- James SollinsDirector
- Dennis P KaneDirector
- Susan CrookstonExecutive Officer
- Donald R ParfetDirector
- Offering amount
- $10.5M
- Amount sold
- $9.7M
- Minimum investment
- $50K
- Proceeds to insiders
- $100K
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Armune BioScience raised?
- Armune BioScience has disclosed $10.2M raised across 2 rounds.
- Where is Armune BioScience headquartered?
- Armune BioScience is headquartered in Kalamazoo, US.